Saccharo

Oakland, United States

Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.

$7.4M raised

Aug 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Saccharo raised?

Saccharo has raised $7.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2022.

Who are Saccharo's investors?

Saccharo's investors include Sand Hill Angels, Life Science Angels, Xandex Investments LLP.

Where is Saccharo headquartered?

Saccharo is headquartered in Oakland, United States.

What does Saccharo do?

Saccharo is a biotech start-up in the immuno-oncology space that develops products for the treatment of cancer and other novel diseases.

What stage is Saccharo at?

Saccharo is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 16, 2022.

MLA

"Saccharo — Funding & Investors." VCBacked, August 16, 2022, https://www.vcbacked.co/company/saccharo. Accessed July 2, 2026.

APA

VCBacked. (2022). Saccharo — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/saccharo

Wikipedia (cite web)

{{cite web |title=Saccharo — Funding & Investors |url=https://www.vcbacked.co/company/saccharo |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 16, 2022.